|
2025 Conference Publication The utility of 24-hour urinary aldosterone concentration analysed by LC-MS/MS for the diagnosis of primary aldosteronismMatthews, Alexandra, Je, David, Thuzar, Moe, He, Jinwen, Ng, Elisabeth, Cowley, Diane, Yang, Jun and Stowasser, Michael (2025). The utility of 24-hour urinary aldosterone concentration analysed by LC-MS/MS for the diagnosis of primary aldosteronism. ENDO 2025 Annual Meeting of the Endocrine Society, San Francisco, CA, United States, 12-15 July 2025. Cary, NC, United States: Oxford University Press. doi: 10.1210/jendso/bvaf149.843 |
|
2025 Conference Publication 24-hour urinary aldosterone measured by immunoassay for the diagnostic work-up of primary aldosteronismNg, Elisabeth, Shen, Hang Qi, Lim, Xin Yi, Marcus, Poh, Gwini, Stella May, Thuzar, Moe, Stowasser, Michael, Fuller, Peter J, Hu, Jinbo and Yang, Jun (2025). 24-hour urinary aldosterone measured by immunoassay for the diagnostic work-up of primary aldosteronism. ENDO 2025 Annual Meeting of the Endocrine Society, San Francisco, CA, United States, 12-15 July 2025. Cary, NC, United States: Oxford University Press. doi: 10.1210/jendso/bvaf149.808 |
|
2024 Conference Publication Cardiometabolic Consequences of Primary AldosteronismThuzar, Moe (2024). Cardiometabolic Consequences of Primary Aldosteronism. Practice Pearls & Updates in Primary Aldosteronism, Adelaide, SA Australia, 13 November 2024. |
|
2024 Conference Publication Optimal Adrenal Vein Sampling Lateralization Criteria For Diagnosis Of Unilateral Primary Aldosteronism Using Aldosterone Concentration Measured By LC-MS/MS Post-ATCH StimulationThuzar, Moe, Zaal, Kassem, Ma, Derrick, Morkos, Michael, McWhinney, Brett, Ungerer, Jacobus and Stowasser, Michael (2024). Optimal Adrenal Vein Sampling Lateralization Criteria For Diagnosis Of Unilateral Primary Aldosteronism Using Aldosterone Concentration Measured By LC-MS/MS Post-ATCH Stimulation. ISH 30th Scientific Meeting, Cartagena, Colombia, 19-22 September 2024. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0001063080.94646.5d |
|
2023 Conference Publication The Mineralocorticoid System – More Than a Regulator of Blood Pressure in the Pathophysiology of Metabolic Syndrome?Thuzar, Moe (2023). The Mineralocorticoid System – More Than a Regulator of Blood Pressure in the Pathophysiology of Metabolic Syndrome?. ESA-SRB 2023 Annual Scientific Meeting, Brisbane, QLD Australia, 26-29 November 2023. |
|
2020 Conference Publication Relationship between the hypothalmic-pituitary-adrenocortical axis activity and the characteristics of aldosterone-producing adenomasThuzar, Moe, Lo, Yu-Chin, Guo, Zeng, Inder, Warrick J. and Stowasser, Michael (2020). Relationship between the hypothalmic-pituitary-adrenocortical axis activity and the characteristics of aldosterone-producing adenomas. 22nd European Congress of Endocrinology, Online, 5 - 9 September 2020. Bristol, United Kingdom: Bioscientifica. doi: 10.1530/endoabs.70.aep47 |
|
2019 Conference Publication Defining the optimal cut-off plasma aldosterone level measured by immunoassay for the diagnosis of primary aldosteronism using seated salines suppression testThuzar, M., Young, K., Ahmed, A., Wolley, M., Guo, Z., Ward, G., McWhinney, B., Ungerer, J. and Stowasser, M. (2019). Defining the optimal cut-off plasma aldosterone level measured by immunoassay for the diagnosis of primary aldosteronism using seated salines suppression test. 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), Milan, Italy, 21-24 June 2019. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000570272.55373.54 |
|
2018 Conference Publication Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over studyThuzar, Moe, Law, W. Phillip, Dimeski, Goce, Stowasser, Michael and Ho, Ken K. Y. (2018). Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over study. Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), Perth Australia, Aug 27-30, 2017. HOBOKEN: WILEY. |
|
2017 Conference Publication Effect of formoterol, a selective beta(2)-adrenergic agonist, on brown adipose tissue function in humans: a double-blind placebo controlled studyThuzar, Moe, Law, W. Phillip, Ratnasingam, Jeyakantha, Franklin, Michael, Dimeski, Goce and Ho, Ken K. Y. (2017). Effect of formoterol, a selective beta(2)-adrenergic agonist, on brown adipose tissue function in humans: a double-blind placebo controlled study. HOBOKEN: WILEY-BLACKWELL. |
